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Abstract Cystic fibrosisis characterizedbyadamagedairwayepitheliumwithinflammationandchronic infection.The
aimof this study was to investigate the process of apoptosis in this disease.To evaluate the effects of interferon g and the
Fas apoptotic pathway on cystic fibrosis airway epithelial cells, we used immortalized cystic fibrosis (CFT-1and CFT-2)
andnormal (NT-1) humantrachealepithelialcelllines.Celldeathwasdeterminedusingannexin-V/propidiumiodidelabel-
ling and electronmicroscopy. In vitro expression of Fas and CD40 surface antigenswas analysed byimmunofluorescence
staining and flow cytometry.Normal and cystic fibrosis cells constitutively express these antigens.CD40, but not Fas
expression, wasupregulatedbyinterferon g.Treatmentof interferon g-stimulatedcellswith anti-Fasresultedinapoptosis
for about 80% of CFT-2 (homozygous forDF508 deletion) cells and for 35--40% of CFT-1 (heterozygous) ornormalcells.
Our results suggestthat Fasmaymediate apoptosis in cystic fibrosis airwayepithelium.r2002 Elsevier Science Ltd
doi:10.1053/rmed.2001.1257, available online at http://www.idealibrary.comon
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Cystic ¢brosis (CF) is an autosomal recessive genetic dis-
order caused by mutations in the cystic ¢brosis trans-
membrane conductance regulator gene (1). It results in
absent or de¢cient expression of CFTR protein (2). The
most common mutation is the DF508 mutation which
has aworldwide prevalence of about 70% of CF chromo-
somes in caucasians (3). CFTR protein is expressed in
epithelial cells of the pancreas, intestine, sweat glands,
upper and lower expiratory tracts. The main cause of
morbidity andmortality in CF is linked to chronic in£am-
matory and infectious bronchial processes which lead to
progressive bronchial damage and lung destruction (4).
CFTR protein is a cAMP-regulated chloride channel and
defective electrolyte transport is believed to be the initi-
al abnormality in CF disease, resulting in alteration of
epithelial secretions (5). Evidence of an intense and sus-
tained airway in£ammation has been reported in several
studies (6). A possible role of CFTR dysfunction in enter-
taining in£ammatory and infectious processes through aReceived 24 April 2001and accepted in revised form13November 2001.
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cociliary clearance and cytokine production, has been
suggested (7).
Programmed cell death or apoptosis is a physiological
process de¢ned by distinct characteristic morphological
and biochemical changes (8). It is essential for the main-
tenance of homeostasis of epithelial organisation and
function and for clearance of in£ammatory cells (9). It is
regulated by several factors, including oxidative stress,
extracellular matrix proteins, and external signals as tu-
mour necrosis factor (TNF)a, CD40 or Fas ligation (10--
12). Fas (CD95) and CD40, two molecules of the plasma
membrane, are involved in the regulation of apoptosis in
di¡erent cellular models, such as lymphocytes (11,12).
CD40, a molecule belonging to the superfamily of the
TNF receptor, was initially detected in B lymphocytes
(13).CD40 signaling does not always deliver an anti-apop-
totic activation (14) and may instead lead to apoptosis
(15--17). Fas antigen (CD95, APO-1), another member of
theTNF receptor family (18), induces apoptosis after en-
gagementwith the Fas ligand (19). Several recent studies
have demonstrated that interferon g (IFNg), alone or in
combination with activation of the Fas pathway, induces
apoptosis in various Fas-expressing cells, such as cul-
tured keratinocytes (20), breast cell lines (21), and
lung epithelial cells (22). There are some discrepancies
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enhance or inhibit apoptosis (16,23).
Apoptosis dysfunction in CF has recently been sug-
gested, but with discordant results. A‘‘resistance’’ in the
initiation of apoptosis induced by etoposide was re-
ported in a mutant DF508 epithelial mouse mammary
cell line, probably due to the inability to obtain cytoplas-
mic acidi¢cation (24). On the other hand, a high DNA
fragmentation and a high level of Fas ligand expression
have been reported in both human CF enterocytes and
bronchial epithelial cells (25,26)
The purpose of this study was to investigate CD40
and Fas expression in human CF and non-CF tracheal
epithelial cell lines and compare the susceptibility of
these cell lines to Fas-mediated apoptosis induced by
anti-Fasmonoclonal antibody with or without IFNg.
MATERIALSANDMETHODS
Human tracheal epithelial cell cultures
Transformed tracheal cell lineswereusedbecause accep-
table quantitative and qualitative primary CF epithelial
cells are di⁄cult to obtain in acceptable quality and
quantity in vitro. Three human SV40-transformed tra-
cheal epithelial cell lines were kindly provided by A. Paul
(INSERM U402, Paris, France). NT-1 cell line deriving
from non-CF human foetus served as control. The two
CF cell lines used in this study were obtained from CF
foetuses with di¡erent mutations in the CFTR gene:
CFT-1 cells which are compound heterozygote for
S549N and N1303K mutations (class III mutations) and
CFT-2 cells which are homozygous for the DF508muta-
tion (class II mutation) (27).
Cells were grown in a 1:1 ratio mixture of Dulbecco’s
minimum essential medium and Ham’s F12 (DMEM/F12,
Gibco) nutrient medium supplemented with 100Uml1
of penicillin, 100mgml1 of streptomycin, 250ngml1 of
amphotericin B and 10% of foetal calf serum (Gibco).
Cellswere incubatedin a humidi¢ed 5%CO2 atmosphere
at 371C until sub-con£uence and the mediumwas chan-
ged three times weekly.
Immuno£uorescence staining and £ow
cytometric analysis
Before reaching sub-con£uence, human tracheal epithe-
lial monolayers were pretreated for 48h with TNFa
(100Uml1, Sigma) or with IFNg (1000Uml1,Genzyme)
prior to immuno£uorescence staining. Cells left un-
treated in culture medium were used as controls. At
sub-con£uence, adherent epithelial cells were detached
by incubationwith EDTA (0?2g l1) for 2--3min.
Surface antigen expression was then performed at
41Cwith CD40 (mAb 89,10mgml1, generously providedby Schering-Plough, Dardilly, France) and Fas (UB2,
5mgml1, Immunotech).
R-phycoerythrin-conjugated anti-mouse immunoglo-
bulin (Ig) alone as well as irrelevant isotype-matched
mouse anti-human IgG1 served as negative controls.
Fluorescence intensity of at least 5103 cells per sample
was analysed using £uorescence-activated cell sorter
(FACS EPICS XL-MCL). The percentage of labelled cells
was evaluated and the mean £uorescence intensities
(MFI) were determined. Statistical analysis of at least six
di¡erent experiments for each cell line was performed
withWilcoxonmatched-pair signed-rank test.
Induction of apoptosis by anti-Fas antibody
and cell death assay
At semicon£uence, cells were either pre-treated or not
with recombinant human IFNg (1000Uml1) for 24h.
Tracheal epithelial cells were then washed and either
treated or not with anti-Fas mAb (IgM, CH-11, 0?1 and
1mgml1, Immunotech) for an additional 48h culture. At
this time, cellswere sub-con£uentexcept for those incu-
bated with IFNg and/or anti-Fas, some of which had de-
tached from the culture surface. Adherent and
nonadherent cells were then harvested, adherent cells
being removed by incubation in trypsin/EDTA whereas
nonadherent cells, detached during the last 48h period,
were recovered by collecting the culturemedium.
After the washing steps, viability and numeration of
cells were determined by trypan blue exclusion.
Apoptosis was assayed with the Annexin-V-FLUOS
Staining Kit from Boehringer Mannheim, according to
the manufacturer’s protocol. Annexin-V-FLUOS binds
speci¢cally to phosphatidylserine exposed after translo-
cation on the outer membrane of apoptotic cells but
cannot react with the innermembrane phosphatidylser-
ine of normal cells. Brie£y, cell suspensions were incu-
bated with annexinV--£uorescein isothiocyanate (FITC)
and propidium iodide for 10--15min at 41C and analysed
by FACS as rapidly as possible.
To di¡erentiate necrotic from apoptotic cells and to
detect ultrastructural apoptotic changes, electron mi-
croscopy was performed on epithelial cells under the
same conditions as IFNg and/or anti-Fas treatment. Ad-
herent cells and supernatants were sequentially ¢xed
with 2% glutaraldehyde in culturemedium at room tem-
perature for15min (2% glutaraldehyde in 0?1MNa caco-
dylate-HCl, pH 7?4 at room temperature, for 15min),
washed three times in cacodylate bu¡er--0?2M sucrose
and post-¢xed with 1% OsO4--0?15M Na cacodylate-
HCl (41C, 30min).Cellswere then contrasted in situwith
3% aqueous uranyl acetate (room temperature, 45min).
After dehydration in graded ethanol, the cell layer was
embedded in epon, polymerized (601C, 48h) and
horizontally sectioned with LKB UltrotomeV.Ultrathin
246 RESPIRATORYMEDICINEsections (60--80nm) were observed with JEOL1200 EX
transmission electronmicroscope.
RESULTS
Antigen expression in vitro
Results of antigen expression analysis by £ow cytometry
are summarized in Fig. 1. Fas and CD40 molecules are
constitutively expressed by the three cell lines.
Fas expressionwas not signi¢cantlymodi¢ed after cy-
tokine treatment. A small increase in the percentage ofBasal TNF IFN
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FIG. 1. Fas (a,b) and CD40 (c,d) expression intracheal epithelial ce
bar graphs representing percentages of positive cells (a,c) and corre
lines (NT-1,&;CFT-1, andCFT-2,&;) were eitherleftuntreated (
IFNg (1000Uml1).Presented results are themeans7SD of 6--10 ex
tistical analysis performedwithWilcoxonmatched-pair signed-rankpositive cellswas onlyobserved after IFNg stimulation of
NT-1 cells. IFNg up-regulated CD40 expression and this
increase was signi¢cant in cystic ¢brosis cells. Stimula-
tionwithTNFa onlyenhanced thenumberof stainedcells
for the homozygous CF cell line (CFT-2).
Fas-induced apoptosis data
To determinewhether the three cell lineswere suscepti-
ble to Fas-mediated apoptosis, Fas mAb was applied to
the cultures during 48h. We investigated the presence
of apoptotic cells using newly described £uorescenceBasal TNF IFN
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FIG. 2. Cell detachment inducedbyanti-Fas antibody.Tracheal
epithelial cells from each cell line, either pre-treated or not with
IFNg for 24 h, were culturedwith 0 (&),0?1 ( )or1 (&)mgml1
of anti-Fas mAb for an additional 48 h period. Non-adherent
cells, detached during this last period, were recovered by col-
lecting the culturemedium and numerated afterwards.The ¢g-
ure shows the results (mean7SD) for three independent
experiments.
FIG. 3. Ultrastructure of apoptosis in human epithelial tracheal ce
and CFT-2 (c) cells treatedwith IFNg+1 mgml1of anti-Fas antibody
nuclear membrane integrity is preserved but cytomembranes are v
tinguished fromthenucleoli (b) (bar=1 mm). (d) Adherentnon apopto
anti-Fas antibody).Thecelliswidelyspread.Thecytoplasmicorganelle
the nuclear envelope contrastingwith large typicalnucleoli (bar=1 m
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were obtained for three experiments. Fas mAb induced
detachment of the cells in the three cell lines and, in all
cases, more than 90% of the detached cells expressed
both AnnexinVand PI, corresponding to advanced apop-
totic cells and necrotic cells. However, the number of de-
tachedcells varied signi¢cantlybetween the three cell lines
as shown in Fig. 2.Treatment alone (1mgml1) induced de-
tachment of 20% of control cells (NT-1), 19% of heterozy-
gous CF cells (CFT-1), and 35% of homozygous CF cells
(CFT-2).With a lower dose of anti-Fas (0?1mgml1), a simi-
lar but less pronounced e¡ect was obtained in all the cell
lines (12, 12 and 21?5%, respectively). Very few detached
cells (5--6%) were detected under basal conditions. Prein-
cubationwith IFNg for 24h enhanced the e¡ectof anti-Fas
mAb (two to three-fold increase of detachment). Treat-
ment with IFNg alone also induced detachment in 11--12%
of NT-1 and CFT-1 cells and 27% of CFT-2 cells. Electron
microscopic ¢ndings (Fig. 3) con¢rmed the presence of
apoptotic rather than necrotic nuclei in tracheal epithelial
cells treated with anti-Fas antibody.Chromatin condensa-
tion and cytoplasmic vacuoles, which are typical features
of apoptosis, were observed in most detached CF [Fig.
3(a--c)] and control (data not shown) cells. On the other
hand, adherent cells did not show apoptotic nuclear
changes [Fig. 3(d)].ll lines. (a, b, c) Detached cystic ¢brosis tracheal cells.CFT-1 (a, b)
.Condensed perinuclear chromatin is observed, cytoplasmic and
esiculated (a, c).Numerous nuclear apoptotic masses can be dis-
ticcontrolcells (NT-1, non-CFcelltreatedwith IFNg+1 mgml1of
s areintact, discretechromatincondensationsare scatteredalong
m).
248 RESPIRATORYMEDICINEIn adherent cells, the percentage of cells expressing
annexin and/or PI did not vary whatever the cell type
or treatment.
DISCUSSION
Our study reveals that both CF and control cultured hu-
man tracheal epithelial cells constitutively express Fas
and CD40 antigens with an upregulation of CD40 ex-
pression by IFNg in the three lines. We have recently
shown that both de¢cient and normal CFTR genotype
cell lines also express Fas receptor ligand (FasL) with a
higher mean £uorescence intensity in CF genotype cells
(26). As these surface antigens are potentially involved in
the apoptotic process, they could play a role in control-
ling epithelial cell turnover.Coexpression of Fas/FasL has
been demonstrated in human airway epithelial cells de-
riving from primary cultures, immortalized cell lines
(28) and in bronchial biopsies fromhealthy (28, 29), asth-
matic (29) and CF (26) subjects, butwith a higher level of
FasL expression in asthmatic and CF patients as com-
paredwith controls (26, 29).The authors suggested that
dysregulation of the Fas/FasL interaction could induce
self or adjacent-cell death, which should result in a high
cell turnover.
The present study also demonstrated that anti-Fas
monoclonal antibody induced apoptosis of human tra-
cheal epithelial cells in vitro in a dose-dependentmanner.
Airway epithelial cells from the three cell lines were
more susceptible to anti-Fas after treatment with IFNg.
This phenomenom, demonstrating that IFNg acts in sy-
nergy with the Fas apoptotic pathway, was also ob-
served in keratinocytes (20) and lung epithelial cells
(22). This could suggest a role for the up-regulation of
CD40 expression by IFNg in the enhanced apoptosis.
The apoptotic function of TNFa did not seem to be
dependent on Fas expression or the Fas pathway.
Interestingly, whereas Fas was similarly expressed in
the three cell types, Fas-induced apoptosiswasmarkedly
increased in homozygous DF508/DF508 CFT-2 cells
(about a two-fold increase) as compared with control
NT-1 cells and heterozygous CFT-1 cells. Fas expression
was not signi¢cantly modi¢ed by IFNg treatment, but
preincubation of cells with IFNg enhanced CFT-2 anti-
Fas cell death induction.
Discrepancies observed in susceptibility to apoptosis
between CFT-1 and CFT-2 still remain to be clari¢ed.
Onehypothesis couldbe that, in the case of homozygous
DF508/DF508 CFT-2 cells, there is an accumulation of
the CFTR mutant protein in the endoplasmic reticulum
that could induce activation of transcriptional factors,
such as nuclear factor kB(NF-kB), which plays an impor-
tant role in apoptosis and in inducing Fas ligand expres-
sion (30).Resistance to induction of apoptosis has been demon-
strated in mouse mammary CF epithelial cells which do
not express the apical CFTR (24). The ‘authors’ hypoth-
esis was the inhability of CF cells to obtain cytoplasmic
acidi¢cation. It has been demonstrated that DF508/
DF508 CF cellsFwhich do not express CFTR protein at
the apical membrane because of accumulation in the en-
doplasmic reticulumFpresent a defect in acidi¢cation
(31). However, in some cell-free models, a pH above 7?4
only suppressed the activity of procaspase-3 but not
the activity of caspase-3, which is a ¢nal common path-
way for most apoptotic signals (32). This suggests that
pH and salt could a¡ect activation of apoptosis by di¡er-
ent pathways and in di¡erent ways. The use of di¡erent
mediators (cycloheximide or etoposide) to induce cell
death could explain the apparent discrepancy with our
results.Furthermore, we do not have information about
Fas expression and susceptibility to anti-Fas antibody in
thismousemammary cell line.
In conclusion,DF508 homozygoushuman tracheal cells
have high susceptibility to Fas-mediated apoptosis, espe-
cially with IFNg pretreatment.Whether this result is re-
lated to the high level of FasL expression remains to be
con¢rmed.The role of enhanced Fasmediated apoptosis
in the dysregulation of in£ammatory and ¢brotic epithe-
lial process observed in CF could be suggested, but
further studies are required.
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